Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Hodgkin Disease 65Lymphoma 39Urinary Bladder Neoplasms 16Carcinoma, Non-Small-Cell Lung 11Melanoma 9Lung Neoplasms 9Urethral Neoplasms 4Recurrence 4Prostatic Neoplasms 4Lymphoma, Large-Cell, Anaplastic 4Testicular Neoplasms 3Neoplasms 3Leukemia 3Glioma 3Central Nervous System Neoplasms 3Astrocytoma 3Testicular Germ Cell Tumor 2Teratoma 2Skin Neoplasms 2Oligodendroglioma 2Neurofibromatosis 1 2Kidney Neoplasms 2HIV Infections 2Carcinoma, Renal Cell 2Breast Neoplasms 2Brain Neoplasms 2Uterine Cervical Neoplasms 1Urothelial Carcinoma of the Bladder 1Ureteral Neoplasms 1Survival Without Progression 1

Interventions

Specimen Handling 2Biopsy 2pembrolizumab 1pegylated granulocyte colony-stimulating factor 1pegfilgrastim 1merphos 1infigratinib 1enfortumab vedotin 1durvalumab 1Vinblastine 1Surgical Procedures, Operative 1Platinum 1Nephroureterectomy 1Methotrexate 1Magnetic Resonance Spectroscopy 1Immunoglobulin G 1Gemcitabine 1Doxorubicin 1Disulfides 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Renal Pelvis and Ureter Urothelial Carcinoma × Vinblastine × Clear all
NCT04628767 2026-06-03

Testing the Addition of MEDI4736 (Durvalumab) to Chemotherapy Before Surgery for Patients With High-Grade Upper Urinary Tract Cancer

National Cancer Institute (NCI)

Phase 2/3 Recruiting
131 enrolled
Genitourinary

Renal Pelvis and Ureter Urothelial Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡